Nous utilisons des cookies pour améliorer votre expérience. Pour nous conformer à la nouvelle directive sur la vie privée, nous devons demander votre consentement à l’utilisation de ces cookies. En savoir plus.
Tolerance in Allogeneic Living-Related Renal Transplantation:
Univ Europeenne - EAN : 9783330869158
Édition papier
EAN : 9783330869158
Paru le : 2 mai 2017
49,90 €
47,30 €
Disponible
Pour connaître votre prix et commander, identifiez-vous
Notre engagement qualité
-
Livraison gratuite
en France sans minimum
de commande -
Manquants maintenus
en commande
automatiquement -
Un interlocuteur
unique pour toutes
vos commandes -
Toutes les licences
numériques du marché
au tarif éditeur -
Assistance téléphonique
personalisée sur le
numérique -
Service client
Du Lundi au vendredi
de 9h à 18h
- EAN13 : 9783330869158
- Réf. fournisseur : 1933825
- Editeur : Univ Europeenne
- Date Parution : 2 mai 2017
- Disponibilite : Disponible
- Barème de remise : NS
- Nombre de pages : 116
- Format : H:229 mm L:152 mm E:7 mm
- Poids : 182gr
- Interdit de retour : Retour interdit
- Résumé : Transplantation tolerance may be defined as normal graft survival sans immunosuppression, maintaining intact immunity. Tolerance induction (TI) strategies include induction of chimerism and/or clonal deletion. Donor specific transfusion (DST) and stem cells (SCs) have come-up as TI. In this parallel 2-armed open labeled study under non-myeloablative conditioning with DST as first arm and SCs as second arm, without using conventional immunosuppression. Monitoring included SCr (mg/dL), DSA and MLR. Protocol biopsies were planned after 100 days and yearly in willing patients. In event of rejection/DSA/MLR, rescue immunosuppression was planned. Patient survival for the first 2 years was 100% in both arms; at 5 years post-transplant 80% with SC and 90% with DST. Death-censored graft survival for 1st year was 100 % in both arms, and at 5 years, 80% with SC and 70% with DST. Mean SCr was 1.52 with SC and 1.97 with DST. Five patients from SC-arm and 3 from DST-arm had successful TI. MLR was negative in both groups. DSA appeared in 2 patients of SC without graft dysfunction and 4 of DST causing graft dysfunction. Thus SCs facilitate TI in LDRT under non-myeloablative conditioning.